Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

148
Pharmaceutical Industry
80
Pharmaceutical Patents
74
Prescription Drugs
71
Patents
67
ANDA
59
Hatch-Waxman
56
Patent Infringement
46
Patent Litigation
34
Biosimilars
29
SCOTUS
24
Preemption
22
Labeling
20
BPCIA
19
FDCA
16
Medical Devices
16
Sandoz
15
Amgen
15
Apotex
14
Appeals
14
Failure To Warn
13
FTC
12
FDA Approval
11
Commercial Marketing
11
Healthcare
11
Manufacturers
11
Popular
11
Reverse Payment Settlement Agreements
11
Warning Labels
10
Biologics
10
PLIVA v Mensing
10
Sandoz v Amgen
9
Antitrust Litigation
9
FTC v Actavis
9
Patent Dance
8
Affordable Care Act
8
Mylan Pharmaceuticals
8
Orphan Drugs
8
Preliminary Injunctions
8
Teva Pharmaceuticals
7
Notice Requirements
7
Orange Book
7
Prior Art
6
Draft Guidance
6
Medicare
6
Mutual Pharmaceuticals v Bartlett
6
Otsuka Pharmaceutical
6
Patent-in-Suit
6
Personal Jurisdiction
6
Safe Harbors
6
Summary Judgment
6
USPTO
5
Actavis Inc.
5
Biologics Price Competition and Innovation Act of 2009
5
Declaratory Judgments
5
Design Defects
5
Medicaid
5
Product Hopping
5
Product Labels
5
Watson Pharmaceuticals
4
aBLA
4
Class Action
4
CMS
4
Corporate Counsel
4
Drug Pricing
4
Exclusivity
4
HHS
4
Life Sciences
4
No-AG Agreement
4
OIG
4
On-Sale Bar
4
Patent Applications
4
Pay-For-Delay
4
Product Exclusivity
4
Proposed Legislation
4
Proposed Regulation
4
Sherman Act
3
AbbVie
3
Allergan Inc
3
Amarin
3
AstraZeneca
3
Classen Immunotherapies
3
Comment Period
3
DOJ
3
Drug Safety
3
Federal Rule 12(b)(6)
3
GDUFA
3
GlaxoSmithKline
3
Health Care Providers
3
Healthcare Reform
3
Hospira
3
Hospitals
3
Inter Partes Review Proceedings
3
Jurisdiction
3
Licensing Rules
3
Medicare Part B
3
Merck
3
Off-Label Promotion
3
Patent Invalidity
3
Pharmacies
3
Pleading Standards
3
Professional Conferences
3
Public Health Service Act
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Spectrum
3
Standing
3
Takeda Pharmaceuticals
3
Telehealth
3
Trademarks
2
21st Century Cures Initiative
2
America Invents Act
2
Antitrust Injuries
2
Antitrust Provisions
2
Biotechnology
2
Brand
2
Canada
2
Cancer
2
CDC
2
Chevron Deference
2
China
2
Citizen Petitions
2
Clinical Trials
2
Co-Op
2
Congressional Committees
2
Congressional Investigations & Hearings
2
Contraceptive Coverage Mandate
2
DaimlerAG
2
DaimlerChrysler v Bauman
2
Dismissals
2
Drug Compounding
2
Durable Medical Equipment
2
Duty to Deal
2
E-Cigarettes
2
Elan Pharmaceuticals
2
Eli Lilly
2
Endo Pharmaceuticals
2
EU
2
False Advertising
2
False Claims Act (FCA)
2
First Amendment
2
Food Safety
2
Foreign Manufacturers
2
Free Speech
2
General Jurisdiction
2
Health Information Technologies
2
Induced Infringement
2
Innovator Liability
2
Intellectual Property Litigation
2
INTERPOL
2
Learned Intermediary
2
Legislative Agendas
2
Medicare Part D
2
MedPAC
2
Medtronic
2
Mensing
2
Mental Health
2
Monopolization
2
Motion To Stay
2
Multidistrict Litigation
2
New Guidance
2
NIH
2
Off-Label Use
2
PHRMA
2
Putative Class Actions
2
Rebates
2
REMS
2
Substance Abuse
2
Suppliers
2
Telemedicine
2
Transfer of Venue
2
TRO
2
Twombly/Iqbal Pleading Standard
2
Unfair Competition
2
Websites
2
Wyeth
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Abbott Laboratories
1
ACOs
1
Actos
1
Advance Notice
1
Allergan v Sandoz
1
Alternative Payment Models (APM)
1
Amended Complaints
1
Amended Regulation
1
Anti-Competitive
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Violations
1
App Developers
1
Australia
1
Automatic Enrollment
1
Barack Obama
1
Bayer
1
Best Practices
1
Bifurcation
1
Biogen Idec
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Books
1
BPCI
1
Burden of Proof
1
CA Supreme Court
1
Cadillac Tax
1
CAFC
1
Cartwright Act
1
Carve Out Provisions
1
Causation
1
Center for Drug Evaluation and Research (CDER)
1
Cephalon
1
Cipro
1
Civil Monetary Penalty
1
Claim Construction
1
Class Certification
1
Clearance
1
Community Trademark
1
Competition
1
Compliance
1
Conflicting Proposals
1
Copyright
1
Copyright Infringement
1
Corrective Actions
1
Cost-Sharing
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Defect
1
Delaware General Corporation Law
1
Department of Veterans Affairs
1
Device Classification
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Purchasers
1
Disclosure
1
Disclosure Requirements
1
Discovery Rule
1
Disgorgement
1
Doctrine of Equivalents
1
DOHA
1
DOL
1
DQSA
1
DSCSA
1
EAR
1
EHR
1
Elder Issues
1
Email
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Evidence Suppression
1
Exceptional Case
1
Expert Testimony
1
Exports
1
False Evidence
1
FDA Warning Letters
1
FDASIA
1
Federal Budget
1
Federal Question Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Fee-for-Service
1
Filing Fees
1
Final Rules
1
First Sale Doctrine
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreseeability
1
Forum Shopping
1
Fraudulent Concealment
1
FTEs
1
Generic
1
Genzyme
1
Gilead Sciences
1
Goodyear
1
Government Investigations
1
Grable Factors
1
Health Insurance
1
Health Safety
1
Highmark v. Allcare
1
Hoffman LaRoche
1
Home Health Care
1
ICD-10
1
Implied Preemption
1
Imports
1
Information Reports
1
Informed Consent
1
Injunctive Relief
1
Inspections
1
Intellectual Property Protection
1
International Harmonization
1
International Treaties
1
Inventions
1
Investors
1
IRF Claim Processing
1
Janssen Pharmaceuticals
1
Johnson & Johnson
1
Justiciable Controversy
1
Kickbacks
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Licenses
1
Long Term Care Facilities
1
Manufacturing Defects
1
Marketing
1
Medical Foods
1
Misrepresentation
1
Mootness
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Dismiss
1
Native American Issues
1
Negligence
1
New Legislation
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Non-Grandfathered Health Plans
1
Notice of Intent
1
Notifications
1
Novartis
1
Nursing Homes
1
Nutritional Supplements
1
Obviousness
1
Octane Fitness v. ICON
1
Open Enrollment
1
OPPS
1
Out-of-State Companies
1
Out-of-State Judgments
1
OxyContin
1
PACE
1
Patent Term Extensions
1
Patent Trial and Appeal Board
1
Patent-Misuse
1
Permanent Injunctions
1
Physician Fee Schedule
1
Physician Medicare Reimbursements
1
Post-Grant Review
1
Premarket Approval Applications
1
Prescription Drug Coverage
1
Presidential Elections
1
Price Transparency
1
Private Right of Action
1
Product Defects
1
Prometheus
1
Public Meetings
1
Public Performance Rights
1
Public Use
1
Qui Tam
1
RanBaxy
1
Recordkeeping Requirements
1
Registration Requirement
1
Regulatory Standards
1
Renewal Fees
1
Res Ipsa Loquitur
1
Research and Development
1
Restraining Orders
1
Reversal
1
Reverse Payments
1
RICO
1
Risk Management
1
Roxane Laboratories
1
Rural Areas
1
Rural Health Care Program
1
SAMHSA
1
SEC
1
Section 340B
1
Senate Judiciary Committee
1
Settlement
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Skilled Nursing Facility
1
SmithKline Beecham
1
SNDAs
1
Social Security
1
Specific Jurisdiction
1
Spoliation
1
Standard of Review
1
State Health Insurance Exchanges
1
State Law Tort Claims
1
Subject Matter Jurisdiction
1
Supply Chain
1
Tax Credits
1
Tobacco Regulations
1
Trade Secrets
1
Trademark Registration
1
Trademark Searches
1
Transvaginal Mesh
1
Two-Midnight Rule
1
U.S. Treasury
1
Uniform Commercial Code (UCC)
1
Universal Health Services Inc v United States ex rel Escobar
1
Vaccinations
1
Veterans
1
Veterinary Products
1
Warner Chilcott
1
Webinars
1
Whistleblowers
1
WIPO
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
WTO